Article Sidebar

Submitted
Jun 5, 2024
Accepted
Jun 27, 2024
Published
Jun 30, 2024
Download
pdf
Statistic
Read Counter : 99 Download : 91

Downloads

Download data is not yet available.

Main Article Content

Abstract

Background: Efforts to reduce the side effects of long-term NSAID use have prompted exploration of transdermal drug delivery, which offers advantages such as avoiding first-pass metabolism, reducing pain, allowing sustained drug release, and improving patient compliance. Dendrimers, specifically polyamidoamine (PAMAM), are attracting attention for their potential in drug delivery. PAMAM has a three-dimensional structure of monodisperses with high amino group density and internal voids suitable for drug encapsulation.


Methods: This research method uses the literature review method which begins with the collection of journals to be reviewed. The article search was conducted on the Pubmed database. Researchers searched with the keyword dendrimer. The two main synthesis methods are convergent and divergent dendrimers.


Results: : Drug molecules can be trapped in dendrimers through hydrogen, hydrophobic, or electrostatic bonds. The advantages of dendrimers include improved solubility, permeability, and targeted drug delivery, while the disadvantages are high cost, toxicity and aggregation. This system has been used in several pain medications.


Conclusions: Dendrimers are macrostructures with unique characteristics such as nanoscopic size, multifunctional surface, and high branching, making them ideal as drug delivery systems. Ketoprofen with PAMAM-type dendrimers showed that PAMAM dendrimers could significantly increase the accumulative amount of permeation of both drugs after 24 hours, compared with the drug suspension without PAMAM dendrimers. Dendrimers are multi-branched monodisperse macrostructures, derived from Greek.

Keywords

Dendrimers Mechanism Drug Anti-Pain

Article Details

Creative Commons License

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

How to Cite
Yusiana Wahyudi, N., & Rahayu, S. (2024). The Dendrimers as Drug Delivery Platforms of the Mechanisms, Benefits, and Use in Anti-Pain: Systematice Literature Review: Drug Delivery Platforms. INDONESIAN JOURNAL OF HEALTH SCIENCES RESEARCH AND DEVELOPMENT (IJHSRD), 6(1), 259–265. https://doi.org/10.36566/ijhsrd/Vol6.Iss1/217

References

  1. Wardoyo, A. V., Oktarlina, R. Z. The Level of Public Knowledge of Analgesic Drugs in Self-Medication to Overcome Acute Pain. Scientific Journal of Health Sandi Husada .2019; (2):156-160.
  2. Ananda, MB. Mesoporous Silica Nanoparticles Sebagai Drug Carrier pada Aplikasi Controlled Drug Delivery System. Jurnal Perancangan, Manufaktur, Material, dan Energi (Jurnal Permadi). 2020;2(3).
  3. Winarti, L. Sistem penghantaran obat tertarget, macam, jenis-jenis sistem penghantaran, dan aplikasinya. STOMATOGNATIC Jurnal Kedokteran Gigi. 2015;10(2):75-81.
  4. Yiyun, C., Na, M., Tongwen, X., Rongqiang, F., Xueyuan, W., Xiaomin, W., & Longping, W. Transdermal Delivery of Nonsteroidal Anti-inflammatory Drugs Mediated By Polyamidoamine (PAMAM) Dendrimers. Journal of pharmaceutical sciences. 2007;96(3):595-602.
  5. Wang, J., Li, B., Qiu, L., Qiao, X., & Yang, H. Dendrimer-based drug delivery systems: history, challenges, and latest developments. Journal of biological engineering. 2022;16(1): 18. https://doi.org/10.1186/s13036-022-00298-5.
  6. Rahmi, D. Dendrimer Review: Definition, Synthesis, Application and Prospective. Journal of Chemistry and Packaging. 2013;35(2),:137-144.
  7. Duan, X. D., Ji, C. J., & Nie, L. Formulation And Development Of Dendrimer-Based Transdermal Patches Of Meloxicam For The Management Of Arthritis. Tropical Journal of Pharmaceutical Research. 2015:14(4), 583-590.
  8. Prajapati, R. N., Tekade, R. K., Gupta, U., Gajbhiye, V., & Jain, N. K. Dendimer-Mediated Solubilization, Formulation Development and In Vitro-in Vivo Assessment of Piroxicam. Molecular Pharmaceutics. 2009;6(3):940-950.
  9. Koç, F. E., & Şenel, M. Solubility Enhancement of Non-Steroidal Anti-Inflammatory Drugs (Nsaids) Using Polypolypropylene Oxide Core Pamam Dendrimers. International Journal of Pharmaceutics. 2013;451(1-2):18-22.
  10. Asthana, A., Chauhan, A. S., Diwan, P. V., & Jain, N. K. Poly(amidoamine) (PAMAM) Dendritic Nanostructures For Controlled Sitespecific Delivery Of Acidic Anti-Inflammatory Active Ingredient. AAPS PharmSciTech. 2005;6(3):E536–E542. doi:10.1208/pt060367
  11. Gupta, U., Agashe, H. B., & Jain, N. K. Polypropylene Imine Dendrimer Mediated Solubility Enhancement: Effect Of Ph And Functional Groups Of Hydrophobes. Journal of pharmacy & pharmaceutical sciences: a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques. 2007;10(3):358-367.
  12. Prajapati, R. N. Polyamidoamine Dendrimer-mediated Formulation Development and In Vitro-In Vivo Evaluation of Ketorolac. Asian Journal of Pharmaceutics (AJP). 2018;12(02).
  13. Prasetyo, M., Tasnim, T., Riski,S. Control of Dead Stock and Slow-Moving Drugs in the Pharmacy Installation of the Kendari City Regional General Hospital. Indonesian Journal of Health Sciences Research and Development.2023, 5(2), 63-72. DOI: https://doi.org/10.36566/ijhsrd/Vol5.Iss2/173.